Submitted by Catherine Atkins on Wed, 23/08/2023 - 15:21
We are delighted to announce that two new eminent scientists have joined the Early Cancer Institute Scientific Advisory Board (SAB).
Joellen Schildkraut
Part of her research focus is on familial cancer and in particular the genetic relationship between breast and ovairan cancers. Joellen was one of the first epidemiologists to understand and promote the concept that histological and molecular subtypes of cancer may have distinct etiologies. Her major contributions have been made to the understanding of traditional epidemiologic risk factors and the genetic and molecular subtypes of ovarian cancer.
Dan Landau
The new members bring an international element to the SAB, whose remit is to advise on the strategic relevance and future direction of the Early Cancer Institute, as well as to provide critical and constructive input into our scientific and translational progress and major decision making.
Director Rebecca Fitzgerald commented: “With this additional expertise that Dan and Joellen bring to the SAB, alongside the existing eminent board members, the Early Cancer Institute is in an excellent position to move forward and achieve its goals.”